Key result
Micra leadless pacemaker insertion was associated with two cases of major right ventricular perforation requiring surgical intervention.
Why the study?
Although Micra leadless pacemakers have demonstrated low rates of cardiac perforation in trials and registries, recent reports indicate higher rates of severe complications compared to transvenous devices.
Case Report (n=2)
Answers are grounded in this paper and cite their sources.
This case report highlights the risk of major right ventricular perforation requiring surgical intervention during leadless pacemaker insertion, contrasting with the low complication rates reported in preapproval trials.
Transcatheter pacing systems are self-contained, leadless, devices that offer the potential benefits of avoiding complications related to pectoral pocket and upper extremity vascular access. These systems in preapproval trials demonstrated excellent safety profile with the incidence of device-related cardiac perforation as low as 1.6% with Micra™ (Medtronic) and 1.3% in Nanostim (Abbott). In post-approval registry of Micra™ TPS, the rate of major complications was even lower than in the investigational study ranging from 0.63% to 0.77%. Recently, published report found much higher rates of need for rescue surgery, shock, tamponade, and death among patients implanted with the Micra™ device when compared with transvenous devices. This case report describes two cases of major right ventricular perforation requiring surgical intervention.
No takes yet. Share an insight, caveat, or question.
Gulkarov et al. (2022) conducted a case report in Right ventricular perforation during leadless pacemaker insertion (n=2). Micra leadless pacemaker insertion was evaluated on Major right ventricular perforation requiring surgical intervention. Micra leadless pacemaker insertion was associated with two cases of major right ventricular perforation requiring surgical intervention.
Synapse has enriched 10 related papers. Consider them for comparative context: